Related Experiment Video
Updated: May 7, 2026
07:11
Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force
Giovanni Quarta1, Alison Muir, Antonios Pantazis
1Heart Hospital, University College London Hospitals Trust, London, UK.
Circulation
|May 25, 2011
Summary
Genetic testing for arrhythmogenic right ventricular cardiomyopathy (ARVC) reveals mutations in 58% of families. The 2010 criteria improve diagnosis, and multiple genetic variants increase disease risk.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Epidemiology
Background:
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is increasingly linked to specific gene mutations.
- Mutation analysis is becoming a key tool in understanding ARVC.
- Understanding genetic factors is crucial for familial risk assessment.
Purpose of the Study:
- Investigate the role of genetic testing in ARVC familial assessment.
- Determine mutation prevalence in known ARVC genes.
- Evaluate penetrance, expressivity, and diagnostic criteria utility.
Main Methods:
- Clinical and molecular genetic evaluation of 210 first-degree and 45 second-degree relatives from 100 ARVC families.
- Analysis included proband disease severity, mutation detection, and assessment using 1994 and 2010 Task Force criteria.
- Statistical analysis of genotype-phenotype correlations and risk associated with genetic variants.
Main Results:
- Causal mutations identified in 58% of ARVC families and 73% of living probands.
- The 2010 ARVC criteria identified more affected relatives (33%) than the 1994 criteria (19%).
- Harboring >1 genetic variant significantly increased risk (OR 4.7) of developing clinical ARVC.
Conclusions:
- ARVC exhibits significant genetic complexity and intrafamilial phenotype variability.
- The 2010 ARVC diagnostic criteria demonstrate improved sensitivity for affected relatives.
- Multiple genetic variants are associated with increased disease risk and contribute to ARVC's phenotypic heterogeneity.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
01:30Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...